文献速递其他结缔组织病

商业ELISA与线性印迹法检测肌炎特异性自身抗体的亚太多中心一致性研究

Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该研究纳入亚太地区7国485例特发性炎症性肌病患者的血清,中心化对比商业ELISA与线性印迹法(LBA)检测7种肌炎特异性自身抗体(MSA)的一致性。结果显示抗Jo-1、抗EJ、抗MDA5和抗TIF1-γ的kappa值超过0.80,而抗PL-7、抗PL-12和抗Mi-2一致性较低;免疫沉淀验证提示LBA对抗PL-7和抗Mi-2存在较高假阳性率,ELISA较LBA更准确。

要点

  • 抗Jo-1的阳性符合率最高(0.98),抗Mi-2最低(0.67),所有MSA的阴性符合率均高(0.97–1)。
  • 抗Jo-1、抗EJ、抗MDA5和抗TIF1-γ的kappa值超过0.80,抗PL-7、抗PL-12和抗Mi-2一致性低。
  • 免疫沉淀验证显示LBA对抗PL-7和抗Mi-2存在较高假阳性率,ELISA较LBA更准确。

核心结论

  • 商业ELISA与LBA检测MSA存在差异,尤其抗PL-7和抗Mi-2,ELISA较LBA更准确。

研究设计与样本

  • 亚太地区7国多中心研究,纳入485例特发性炎症性肌病患者血清,中心化使用商业ELISA和LBA检测7种MSA,计算阳性符合率、阴性符合率和Cohen‘s kappa,对结果不一致血清行免疫沉淀验证。

主要发现

  • 阳性符合率:抗Jo-1为0.98,抗PL-7为0.94,抗EJ为0.93,抗MDA5为0.93,抗TIF1-γ为0.89,抗PL-12为0.78,抗Mi-2为0.67。
  • 所有MSA的阴性符合率范围为0.97至1。
  • kappa值超过0.80见于抗Jo-1、抗EJ、抗MDA5和抗TIF1-γ,抗PL-7、抗PL-12和抗Mi-2的kappa值较低。
  • 免疫沉淀验证显示LBA对抗PL-7和抗Mi-2存在较高假阳性率。

临床怎么用

  • ELISA检测MSA较LBA更准确,解读LBA抗PL-7和抗Mi-2阳性结果时需警惕假阳性,必要时用免疫沉淀等方法验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Laboratory detection of myositis-specific autoantibodies (MSAs) utilizes ELISA and multianalyte line blot assays (LBA). We sought to evaluate the concordance and reliability of these two commercial assays. METHODS: Serum samples from patients with idiopathic inflammatory myopathies (IIMs) were obtained from seven countries across the Asia-Pacific region. Anti-Jo-1, anti-EJ, anti-PL-7, anti-PL-12, anti-MDA5, anti-Mi-2 and anti-TIF1-γ antibodies were centrally measured with commercial ELISA and LBA kits. The positive percentage agreement (PPA), negative percentage agreement (NPA) and Cohen's kappa were calculated by comparing the two assays. Sera with discordant results were subjected to 'gold-standard' immunoprecipitation (IP) assays. RESULTS: Serum samples obtained from 485 patients with IIMs, including 180 with DM, 44 with amyopathic DM, seven with JDM, 197 with PM or immune-mediated necrotizing myopathy and 57 with IBM, were subjected to ELISA and LBA. The PPA was the highest for anti-Jo-1 at 0.98, followed by 0.94 for anti-PL-7, 0.93 for anti-EJ, 0.93 for anti-MDA5, 0.89 for anti-TIF1-γ, 0.78 for anti-PL-12 and 0.67 for anti-Mi-2, whereas the NPA was high (ranging from 0.97 to 1 for all MSAs). Kappa values exceeded 0.80 for anti-Jo-1, anti-EJ, anti-MDA5 and anti-TIF1-γ, whereas anti-PL-7, anti-PL-12 and anti-Mi-2 exhibited low values. IP assays using sera with discordant results revealed a high rate of false positives for anti-PL-7 and anti-Mi-2 in LBA. CONCLUSION: Discrepancies in the measurement results were observed between commercially available ELISA and LBA, especially for anti-PL7 and anti-Mi-2. ELISA is more accurate than LBA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Gono T, Limaye V, Gupta L, et al. Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region. Rheumatology (Oxford). 2026. PMID: 42302764. doi:10.1093/rheumatology/keag306

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。